Stay updated on Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added 'Bladder cancer' as a related topic and added 'MedlinePlus Genetics' as a related topic.
    Difference
    0.2%
    Check dated 2026-04-04T06:19:00.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and the previous Revision: v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-21T01:07:21.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Removed the 'Bladder cancer' topic and the 'MedlinePlus Genetics' related topics from the page.
    Difference
    0.2%
    Check dated 2026-03-13T22:36:13.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added. Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-06T18:39:36.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    - Added related topics: Bladder cancer and MedlinePlus Genetics to the page.
    Difference
    0.2%
    Check dated 2026-02-27T19:01:05.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.4.2 and no longer lists Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:55:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Intermediate Risk NMIBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Intermediate Risk NMIBC Clinical Trial page.